PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-241

  1. 583 Posts.
    lightbulb Created with Sketch. 134
    Interesting post and no doubt a bit frustrated with the share price like we all are. I try to remove my emotions which is easier said than done. I didn't sell at $1.70 so I am definitely not selling at $1.10. There is definitely an algo working the price currently and there is not a lot we can do about it. Look for all the old tricks - trades every few minutes, increase in volume, downticking and of course making sure we close near or at the low for the day. I don't recall PR talking about selling MPS asset until late last year and more recently about a potential deal in the second half of this year. They still need to get MPS VI fully recruited and he mentioned that should happen shortly. Whether they wait for top-line readout (4th quarter) or pull trigger beforehand who knows. I have reset my expectations for a deal first quarter of next year. But agree, a deal needs to be delivered to validate the business model.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.